The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 27, 2017
Filed:
Oct. 16, 2014
Applicant:
Medgenics Medical Israel Ltd., Misgav, IL;
Inventors:
Andrew L. Pearlman, D. N. Misgav, IL;
Baruch S. Stern, Haifa, IL;
Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 35/12 (2015.01); A61K 48/00 (2006.01); A61K 31/70 (2006.01); A61K 38/18 (2006.01); A61K 38/21 (2006.01); A61K 47/48 (2006.01); C07K 14/505 (2006.01); C12N 7/00 (2006.01); C12N 15/86 (2006.01); C12N 15/88 (2006.01); A61K 35/36 (2015.01);
U.S. Cl.
CPC ...
A61K 48/0066 (2013.01); A61K 31/70 (2013.01); A61K 35/36 (2013.01); A61K 38/1816 (2013.01); A61K 38/212 (2013.01); A61K 47/48776 (2013.01); A61K 48/0075 (2013.01); A61K 48/0091 (2013.01); C07K 14/505 (2013.01); C12N 7/00 (2013.01); C12N 15/86 (2013.01); C12N 15/88 (2013.01); C12N 2710/10343 (2013.01);
Abstract
The present invention is directed to long-lasting erythropoietin therapeutic formulations and their methods of use wherein the formulation comprises a genetically modified micro-organ that comprises a vector which comprises a nucleic acid sequence operably linked to one or more regulatory sequences, wherein the nucleic acid sequence encodes erythropoietin.